Dexcom is the famous Corporate Investor, which was founded in 1999. The fund was located in North America if to be more exact in United States. The leading representative office of defined Corporate Investor is situated in the San Diego.
The common things for fund are deals in the range of 50 - 100 millions dollars. The fund is constantly included in less than 2 deals per year. The high activity for fund was in 2019.
Among the most popular portfolio startups of the fund, we may highlight Beta Bionics. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. Among the most successful fund investment fields, there are Medical Device, Artificial Intelligence. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States.
This organization was formed by John Burd.
The standard case for the fund is to invest in rounds with 4 partakers. Despite the Dexcom, startups are often financed by Novo Nordisk, RTW Investments LLC, Eventide Asset Management. The meaningful sponsors for the fund in investment in the same round are Zealand Pharma, RTW Investments LLC, Eventide Asset Management.
Related Funds
| Fund Name | Location |
| ADS Global Partners | Japan, Tokyo |
| Andrea Holdings International | - |
| Asia-Pac eCommerce | - |
| Bain Capital | Boston, Massachusetts, United States |
| China Digital Video Holdings Limited | Beijing, Beijing, China |
| Desheng Asset Management | China, Guangdong, Shenzhen |
| GAN Ventures | Colorado, Denver, United States |
| Heron Rock Fund | Canada, Ontario, Ottawa |
| Monterro | Stockholm, Stockholm County, Sweden |
| Morgan Stanley Dean Witter | New York, New York, United States |
| PA Grand Opportunity | - |
| Pioneer Square Labs | Seattle, United States, Washington |
| Rimco Investments | - |
| SEA Fund | Bangalore, India, Karnataka |
| SNK (GSYO) | - |
| Swiss Capacity Building Facility | Switzerland, Zürich, Zurich |
| Takram | Japan, Tokyo |
| TOMS Shoes | California, Los Angeles, United States |
| Yitian Keji | China, Hangzhou, Zhejiang |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Current Health | $4M | 17 Jun 2020 | Boston, Massachusetts, United States | ||
Beta Bionics | $63M | 10 Jan 2019 | Boston, Massachusetts, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Current Health | $4M | 17 Jun 2020 | Boston, Massachusetts, United States | ||
Beta Bionics | $63M | 10 Jan 2019 | Boston, Massachusetts, United States |
